Cargando…
467 Analysis of Clinical and Economical Outcomes of Fidaxomicin Use for Clostridium difficile infections
Autores principales: | Flaherty, Sarah, Lock, John, Bochan, Markian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782130/ http://dx.doi.org/10.1093/ofid/ofu052.333 |
Ejemplares similares
-
1653 Results of a Treatment Protocol Encouraging First-Line Use of Fidaxomicin for Select Patients with Clostridium difficile Infection (CDI)
por: Navalkele, Bhagyashri, et al.
Publicado: (2014) -
762 Outpatient Parenteral Antimicrobial Therapy (OPAT) Treatment Center as Part of Integrated Care Delivery – Single-Center Experience from the First Three Years of Operation
por: Bochan, Markian, et al.
Publicado: (2014) -
1634 Clinical Characteristics of Relapses AND Reinfections in Clostridium difficile Infection
por: Kim, Jieun, et al.
Publicado: (2014) -
1646 Evidence of hospital-associated Clostridium difficile transmission between patients with asymptomatic carriage and patients with Clostridium difficile infection
por: Galdys, Alison, et al.
Publicado: (2014) -
525 Epidemiology and burden of recurrent Clostridium difficile infections
por: Sheitoyan-Pesant, Caroline, et al.
Publicado: (2014)